
Thankful and Fearful
By CAC2 Individual Member Joe Baber Because of my grandson, Conor, a neuroblastoma survivor, I have met so many people in our childhood cancer community
By CAC2 Individual Member Joe Baber Because of my grandson, Conor, a neuroblastoma survivor, I have met so many people in our childhood cancer community
[vc_row][vc_column][vc_column_text] By CAC2 Member Mary Beth Collins, PREP4Gold For the entire month of September the world hears a great deal from the childhood cancer community,
[vc_row][vc_column][vc_column_text] By CAC2 Member Susan Guisto (Friends of Cathryn Foundation) and Guest Blogger Judith G. Villablance, MD, Children’s Hospital Los Angeles Every year, approximately 1
[vc_row][vc_column][vc_column_text] By CAC2 Member Sarah Bartosz, Beat Childhood Cancer This collaborative research effort was due in part to childhood cancer groups coming together as part
[vc_row][vc_column][vc_single_image image=”11180″ img_size=”full”][vc_column_text] By CAC2 Member Patti Gustafson, Swifty Foundation For years we looked to medical professionals to tell us what we needed to know
[vc_row][vc_column][vc_column_text] By CAC2 Member Carolyn Breinich In 2019, I attended my first CAC2 Summit in Columbus, Ohio. It was there where Mariah, a 40-year survivor,
[vc_row][vc_column][vc_column_text] By CAC2 Member Joe Baber If the Creating Hope Act (S. 4010) does not pass the Senate by December 11, THIS YEAR we will lose the best tool
[vc_row][vc_column][vc_column_text] By CAC2 Member Bob Piniewski, People Against Childhood Cancer [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Childhood cancer statistics, like all statistics (1), can be confusing. Any statistic can be used
[vc_row][vc_column][vc_column_text] By CAC2 Member Mariah Forster Olson, Neuroblastoma Children’s Cancer Society [/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]As a long-term childhood cancer survivor with numerous late effects, I have had 39
[vc_row][vc_column][vc_column_text] By CAC2 Member Cesare Spadoni (aPODD). [/vc_column_text][vc_empty_space][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]“Pharma and biotech companies do not develop drugs for kids with cancer!” How many times have we